학술논문

Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study.
Document Type
Letter
Source
Annals of Internal Medicine. 10/19/2021, Vol. 174 Issue 10, p1483-1487. 5p. 1 Diagram, 1 Chart.
Subject
*COVID-19
*SICKLE cell anemia
*COHORT analysis
Language
ISSN
0003-4819
Abstract
I Background: i Sickle cell disease is a collection of compound heterozygote hemoglobinopathies, including sickle cell anemia ([1]). Adjusted HRs with 95% CIs for the observed associations between sickle cell disease and sickle cell trait with COVID-19-related hospitalization and COVID-19-related death; the reference group is persons without any sickle cell disorder. I Discussion: i Our analysis estimated a 4-fold increased risk for COVID-19-related hospitalization and a 2.6-fold increased risk for COVID-19-related death for sickle cell disease. [Extracted from the article]